HCA Healthcare Inc (NYSE:HCA) SVP Sandra L. Morgan sold 3,698 shares of the business’s stock in a transaction dated Tuesday, February 6th. The stock was sold at an average price of $96.91, for a total transaction of $358,373.18. Following the transaction, the senior vice president now owns 5,410 shares in the company, valued at $524,283.10. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink.
Shares of HCA Healthcare Inc (HCA) traded down $0.31 during mid-day trading on Wednesday, reaching $98.40. 1,895,121 shares of the company’s stock traded hands, compared to its average volume of 2,557,820. The company has a market capitalization of $33,570.32, a price-to-earnings ratio of 16.57, a price-to-earnings-growth ratio of 0.96 and a beta of 0.48. The company has a current ratio of 1.62, a quick ratio of 1.36 and a debt-to-equity ratio of -6.58. HCA Healthcare Inc has a twelve month low of $71.18 and a twelve month high of $106.84.
HCA Healthcare (NYSE:HCA) last announced its quarterly earnings data on Tuesday, January 30th. The company reported $2.12 EPS for the quarter, topping the consensus estimate of $1.87 by $0.25. The business had revenue of $11.56 billion for the quarter, compared to analyst estimates of $11.19 billion. HCA Healthcare had a net margin of 4.89% and a negative return on equity of 49.49%. The company’s revenue for the quarter was up 8.7% on a year-over-year basis. During the same quarter in the previous year, the firm posted $1.80 earnings per share. analysts expect that HCA Healthcare Inc will post 8.71 earnings per share for the current year.
HCA has been the topic of several analyst reports. SunTrust Banks set a $90.00 price target on shares of HCA Healthcare and gave the stock a “buy” rating in a report on Sunday, October 15th. Cantor Fitzgerald restated a “buy” rating and set a $95.00 price target on shares of HCA Healthcare in a report on Friday, October 13th. Jefferies Group restated a “buy” rating and set a $92.00 price target on shares of HCA Healthcare in a report on Friday, October 13th. Robert W. Baird set a $86.00 price target on shares of HCA Healthcare and gave the stock a “buy” rating in a report on Thursday, October 19th. Finally, Oppenheimer restated a “buy” rating and set a $90.00 price target (down from $95.00) on shares of HCA Healthcare in a report on Thursday, October 19th. Three research analysts have rated the stock with a sell rating, six have given a hold rating and eighteen have given a buy rating to the company’s stock. The stock has a consensus rating of “Buy” and an average price target of $103.65.
Hedge funds have recently made changes to their positions in the business. Atlantic Trust LLC bought a new stake in HCA Healthcare in the second quarter worth about $118,000. BB&T Investment Services Inc. bought a new stake in HCA Healthcare in the second quarter worth about $141,000. Kovack Advisors Inc. bought a new stake in HCA Healthcare in the fourth quarter worth about $234,000. Checchi Capital Advisers LLC bought a new stake in HCA Healthcare in the fourth quarter worth about $267,000. Finally, Massey Quick Simon & CO. LLC bought a new stake in HCA Healthcare in the third quarter worth about $251,000. 74.89% of the stock is currently owned by institutional investors and hedge funds.
About HCA Healthcare
HCA Healthcare, Inc, formerly HCA Holdings, Inc, is a holding company. The Company, through its subsidiaries, owns and operates hospitals and related healthcare entities. As of December 31, 2016, the Company operated in two geographically organized groups, including the National and American Groups. As of December 31, 2016, the National Group included 84 hospitals, which were located in Alaska, California, Florida, southern Georgia, Idaho, Indiana, northern Kentucky, Nevada, New Hampshire, South Carolina, Utah and Virginia.
Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.